Hematoma regression: a therapeutic target for intracerebral hemorrhage / 国际脑血管病杂志
International Journal of Cerebrovascular Diseases
; (12): 631-635, 2022.
Article
in Zh
| WPRIM
| ID: wpr-954183
Responsible library:
WPRO
ABSTRACT
The disability and mortality rate of patients with intracerebral hemorrhage are very high. At present, there is no effective treatment to improve the outcome of patients with intracerebral hemorrhage. Mechanical compression of hematoma and release of toxic products are the main causes of primary and secondary brain injury in patients with intracerebral hemorrhage, while safe and effective acceleration of hematoma regression is the key strategy to improve the neurological deficit in patients with intracerebral hemorrhage. Microglia/macrophages are the main phagocytic system that mediates hematoma clearance and are mainly polarized into M1 and M2 phenotypes. Cell surface receptors and possible signal transduction pathways play an important role in regulating the endogenous hematoma regression mediated by microglia/macrophages, and may become a new target for clinical treatment of intracerebral hemorrhage and improvement of the outcomes of patients in the future.
Full text:
1
Database:
WPRIM
Language:
Zh
Journal:
International Journal of Cerebrovascular Diseases
Year:
2022
Type:
Article